PEARfect Tone® is a next-generation biomimetic active engineered to sustain the skin under the combined impact of UV, visible and infrared radiation. Designed as a sun-protection booster and phototolerance enhancer, it draws on a refined phytocomplex — derived from the light-adapted pear peel, naturally enriched in protective phenolics — to modulate the key molecular processes that shape the skin’s multispectral photobiological response.
Multispectral exposure activates a coordinated series of stress pathways: UV radiation initiates early melanogenic signaling through tyrosinase activation; visible light amplifies oxidative and pro-inflammatory mediators; and infrared radiation induces protein-unfolding stress and mitochondrial ROS, elevating heat-shock markers including HSP72. With cumulative exposure, these pathways remain persistently engaged, progressively reducing photoprotection capacity and increasing susceptibility to erythema, chromatic instability and pigment accumulation.
By modulating these upstream mechanisms, PEARfect Tone® helps maintain cutaneous functional homeostasis during light-driven stress. It contributes to reduced reactivity, supports tone uniformity preservation, and improves the skin’s adaptive response to repeated UV exposure — addressing a critical dimension of the modern skin exposome.
EFFICACY TEST
IR-induced protein stress modulation (HSP72)
Rationale
Infrared radiation and thermal load destabilize proteins and increase mitochondrial ROS, triggering marked upregulation of the heat-shock marker HSP72 — a key indicator of photothermal stress.
Model
Human keratinocytes were exposed to IR (850 nm) combined with controlled heat (42°C). PEARfect Tone® was applied at graded concentrations and HSP72 expression was quantified.
Outcome
A significant decrease in HSP72 overexpression (up to –46.7% vs stressed control) confirmed mitigation of IR-induced protein stress.
Meaning
By moderating photothermal stress signalling, PEARfect Tone® supports protein homeostasis and contributes to maintaining cellular balance under multispectral exposure.
Early melanogenic activation attenuation (tyrosinase)
Rationale
UV radiation rapidly activates tyrosinase, the rate-limiting enzyme of melanogenesis. Modulating this early enzymatic trigger helps prevent the initiation of pigment-generating signalling.
Model
Tyrosinase activity was quantified via colorimetric assay following application of PEARfect Tone® at multiple concentrations.
Outcome
Tyrosinase activity significantly decreased (up to –26.4%), indicating attenuation of early melanogenic activation.
Meaning
By modulating this upstream trigger, PEARfect Tone® helps limit excessive melanogenic signalling before visible chromatic changes develop.
Limitation of melanin accumulation (3D reconstructed epidermis)
Rationale
Repeated UV exposure leads to progressive melanin accumulation in the epidermis, contributing to tone irregularities and pigment build-up.
Model
A 3D reconstructed human epidermis was irradiated with UVA and UVB. PEARfect Tone® was applied at two concentrations and melanin content was quantified.
Outcome
Melanin accumulation was significantly reduced (up to –68% vs irradiated control), bringing values closer to the non-irradiated baseline.
Meaning
By limiting UV-induced melanin build-up, PEARfect Tone® supports long-term tone stability under recurrent solar exposure.
Improved tolerance to UV exposure (Minimal Erythema Dose)
Rationale
The Minimal Erythema Dose (MED) represents the threshold UV dose required to elicit visible erythema. An increase in MED indicates improved biological tolerance to UV-induced stress.
Study
In a 28-day split-area in vivo study (n=22), a cream containing 5% PEARfect Tone® was compared with placebo. MED was determined using a calibrated solar simulator.
Outcome
The PEARfect Tone®–treated area showed a +24.5% MED increase after 28 days, meaning a higher UV dose was required to trigger redness.
Meaning
The MED increase confirms enhanced biological tolerance to UV exposure, supporting PEARfect Tone®’s positioning as a phototolerance enhancer and sun-boosting active.
Perceived benefits after sun exposure (self-assessment)
Rationale
Perceptual evaluations complement biomarker data by assessing visible and sensorial improvements under real-use conditions.
Study
In the same 28-day in vivo study, volunteers assessed tone evenness, brightness, redness, hydration and comfort after UV exposure.
Outcome
PEARfect Tone® consistently outperformed placebo, with participants reporting reduced redness, improved radiance and tone homogeneity and great comfort after sun exposure.
Meaning
Perceived results align with instrumental outcomes, indicating that the biological actions of PEARfect Tone® translate into visible, clinically relevant improvements.
Collectively, the findings establish a coherent, mechanism-supported efficacy profile, validated across cellular, tissue and clinical levels.
